Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease. | Signal Transduct Target Ther | 2023 | 37980330 | PubTator, text mining | PubMed |
| COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B. | Immune Netw | 2023 | 37970236 | PubTator, text mining | PubMed |
| Single-cell atlas of healthy human blood unveils age-related loss of NKG2C+GZMB-CD8+ memory T cells and accumulation of type 2 memory T cells. | Immunity | 2023 | 37963457 | PubTator, text mining | PubMed |
| Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer. | J Transl Med | 2023 | 37950236 | PubTator, text mining | PubMed |
| NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics? | Front Immunol | 2023 | 37928543 | PubTator, text mining | PubMed |
| Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. | Sci Rep | 2023 | 37923825 | PubTator, text mining | PubMed |
| SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells. | Nat Immunol | 2023 | 37919524 | PubTator, text mining | PubMed |
| A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37919459 | PubTator, text mining | PubMed |
| Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function. | Front Immunol | 2023 | 37908353 | PubTator, text mining | PubMed |
| Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humans. | Front Immunol | 2023 | 37908349 | PubTator, text mining | PubMed |
| Tumor vaccines: Toward multidimensional anti-tumor therapies. | Hum Vaccin Immunother | 2023 | 37905395 | PubTator, text mining | PubMed |
| Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells. | Front Immunol | 2023 | 37901227 | PubTator, text mining | PubMed |
| RNA Editing-Dependent and -Independent Roles of Adenosine Deaminases Acting on RNA Proteins in Herpesvirus Infection-Hints on Another Layer of Complexity. | Viruses | 2023 | 37896783 | PubTator, text mining | PubMed |
| Unraveling the Immunopathological Landscape of Celiac Disease: A Comprehensive Review. | Int J Mol Sci | 2023 | 37895160 | PubTator, text mining | PubMed |
| Innate Immunity in Autoimmune Thyroid Disease during Pregnancy. | Int J Mol Sci | 2023 | 37895126 | PubTator, text mining | PubMed |
| Intervention Effects of Physical Activity on Type 2 Diabetic Patients Potentially Infected with COVID-19. | Medicina (Kaunas) | 2023 | 37893490 | PubTator, text mining | PubMed |
| Integration of machine learning to identify diagnostic genes in leukocytes for acute myocardial infarction patients. | J Transl Med | 2023 | 37891664 | PubTator, text mining | PubMed |
| Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153). | Pathogens | 2023 | 37887757 | PubTator, text mining | PubMed |
| An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer. | Res Sq | 2023 | 37886475 | PubTator, text mining | PubMed |
| Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity. | Front Virol | 2023 | 37886042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=12